José M. Benítez-del-Castillo , Bárbara Burgos-Blasco
{"title":"西班牙干眼病患病率:一项基于人群的调查(PrevEOS)","authors":"José M. Benítez-del-Castillo , Bárbara Burgos-Blasco","doi":"10.1016/j.jtos.2025.01.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To determine the countrywide prevalence of dry eye disease (DED) at the population level in Spain, and associated risks.</div></div><div><h3>Methods</h3><div>This was a cross-sectional study based on a telephone survey conducted in 2022. Participants from the general population were selected by sex, age, region, and population of residence to ensure the representativeness of the Spanish population. Participants responded to 42 questions on sociodemographic characteristics, clinical diagnosis of DED, DED-related symptoms, comorbidities, prior eye surgery, current intake of specific drugs, use of contact lenses or artificial tears, and the use of digital screens. The criteria from the Women's Health Study (WHS) and the Beijing Eye Study (BES) were used to determine DED.</div></div><div><h3>Results</h3><div>A total of 3019 interviews were conducted. The prevalence of DED according to WHS criteria was 16.6 % (10.9 % men versus 21.3 % women, p < 0.001); 12.3 % of respondents reported having a clinical diagnosis of DED. The age group 18–29 years presented a high frequency of symptoms. According to the BES criteria, the prevalence of DED was 22.5 % (20.2 % of men, 24.6 % of women, p = 0.005). Diabetes, glaucoma, and blepharitis, the intake of antidepressants/anxiolytics, blood pressure drugs, and sleeping pills, and prior eye surgery were significant risk factors (p < 0.0001). The use of digital screens for <6 h per day was significantly associated with DED.</div></div><div><h3>Conclusions</h3><div>Prevalence of DED in Spain was high among young adults, who presented a combination of high frequency of symptoms and low rates of clinical diagnosis. Increased awareness should be promoted in this population group.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"36 ","pages":"Pages 126-133"},"PeriodicalIF":5.9000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of dry eye disease in Spain: A population-based survey (PrevEOS)\",\"authors\":\"José M. Benítez-del-Castillo , Bárbara Burgos-Blasco\",\"doi\":\"10.1016/j.jtos.2025.01.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><div>To determine the countrywide prevalence of dry eye disease (DED) at the population level in Spain, and associated risks.</div></div><div><h3>Methods</h3><div>This was a cross-sectional study based on a telephone survey conducted in 2022. Participants from the general population were selected by sex, age, region, and population of residence to ensure the representativeness of the Spanish population. Participants responded to 42 questions on sociodemographic characteristics, clinical diagnosis of DED, DED-related symptoms, comorbidities, prior eye surgery, current intake of specific drugs, use of contact lenses or artificial tears, and the use of digital screens. The criteria from the Women's Health Study (WHS) and the Beijing Eye Study (BES) were used to determine DED.</div></div><div><h3>Results</h3><div>A total of 3019 interviews were conducted. The prevalence of DED according to WHS criteria was 16.6 % (10.9 % men versus 21.3 % women, p < 0.001); 12.3 % of respondents reported having a clinical diagnosis of DED. The age group 18–29 years presented a high frequency of symptoms. According to the BES criteria, the prevalence of DED was 22.5 % (20.2 % of men, 24.6 % of women, p = 0.005). Diabetes, glaucoma, and blepharitis, the intake of antidepressants/anxiolytics, blood pressure drugs, and sleeping pills, and prior eye surgery were significant risk factors (p < 0.0001). The use of digital screens for <6 h per day was significantly associated with DED.</div></div><div><h3>Conclusions</h3><div>Prevalence of DED in Spain was high among young adults, who presented a combination of high frequency of symptoms and low rates of clinical diagnosis. Increased awareness should be promoted in this population group.</div></div>\",\"PeriodicalId\":54691,\"journal\":{\"name\":\"Ocular Surface\",\"volume\":\"36 \",\"pages\":\"Pages 126-133\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ocular Surface\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S154201242500014X\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Surface","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S154201242500014X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Prevalence of dry eye disease in Spain: A population-based survey (PrevEOS)
Purpose
To determine the countrywide prevalence of dry eye disease (DED) at the population level in Spain, and associated risks.
Methods
This was a cross-sectional study based on a telephone survey conducted in 2022. Participants from the general population were selected by sex, age, region, and population of residence to ensure the representativeness of the Spanish population. Participants responded to 42 questions on sociodemographic characteristics, clinical diagnosis of DED, DED-related symptoms, comorbidities, prior eye surgery, current intake of specific drugs, use of contact lenses or artificial tears, and the use of digital screens. The criteria from the Women's Health Study (WHS) and the Beijing Eye Study (BES) were used to determine DED.
Results
A total of 3019 interviews were conducted. The prevalence of DED according to WHS criteria was 16.6 % (10.9 % men versus 21.3 % women, p < 0.001); 12.3 % of respondents reported having a clinical diagnosis of DED. The age group 18–29 years presented a high frequency of symptoms. According to the BES criteria, the prevalence of DED was 22.5 % (20.2 % of men, 24.6 % of women, p = 0.005). Diabetes, glaucoma, and blepharitis, the intake of antidepressants/anxiolytics, blood pressure drugs, and sleeping pills, and prior eye surgery were significant risk factors (p < 0.0001). The use of digital screens for <6 h per day was significantly associated with DED.
Conclusions
Prevalence of DED in Spain was high among young adults, who presented a combination of high frequency of symptoms and low rates of clinical diagnosis. Increased awareness should be promoted in this population group.
期刊介绍:
The Ocular Surface, a quarterly, a peer-reviewed journal, is an authoritative resource that integrates and interprets major findings in diverse fields related to the ocular surface, including ophthalmology, optometry, genetics, molecular biology, pharmacology, immunology, infectious disease, and epidemiology. Its critical review articles cover the most current knowledge on medical and surgical management of ocular surface pathology, new understandings of ocular surface physiology, the meaning of recent discoveries on how the ocular surface responds to injury and disease, and updates on drug and device development. The journal also publishes select original research reports and articles describing cutting-edge techniques and technology in the field.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.
Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center